Robert Florence is a registered patent attorney who focuses his practice on patents and trademarks, as well as related business litigation with specific emphasis on complex pharmaceutical patent litigation brought under the Hatch-Waxman Act. He is known nationally for his Abbreviated New Drug Application (ANDA) work and has extensive experience counseling generic pharmaceutical companies regarding pre-litigation strategies and defending such companies in patent litigation.
Robert handles litigation from inception through trial and has litigated cases before both state and federal courts and the American Arbitration Association. He has negotiated and prepared commercial agreements that include licensing, assignment of rights, development, indemnification, nondisclosure, noncompete, employment and settlement agreements.
He has prosecuted domestic and international patent applications in a variety of arts, including mechanical, chemical, biotechnology, and medical devices. Robert has:
- Conducted intellectual property searches.
- Prepared patent and trademark applications.
- Managed intellectual property portfolios that include the payment of maintenance, renewal, and annuity fees for domestic and international cases.
- Drafted patentability, product clearance, non-infringement, invalidity, and trademark availability opinions.
- Prepared responses to patent and trademark office actions.
- Performed intellectual property audits.
Before practicing law, Robert taught science as a secondary school teacher and held teaching certifications in biology, chemistry, and physical science. While earning his law degree from the University of New Hampshire School of Law he was honored with a merit scholarship and served as an articles editor and then as a senior editor for IDEA: The Journal of Law and Technology.